SEONGNAM, South Korea, Aug. 3, 2023 /PRNewswire/ -- Rznomics developed a novel platform technology termed 'self-circularized RNA structure' that can efficiently and simply generate circular RNA and ...
RNA-based vaccines were the heroes of the COVID-19 pandemic. They set records for the highest-grossing drug launches in history, and their development was recognized in this year’s Nobel Prize in ...
The Mass General Brigham Gene and Cell Therapy Institute (GCTI) today announced it has launched the RNA Therapeutics Core, a first-of-its-kind, state-of-the-art facility and resource to advance the ...
Afrotech on MSN
Biotech Startup CircNova Raises $3.3M Seed Round To Advance AI-Driven Circular RNA Therapies
CircNova, a Michigan-based biotech startup, has completed a $3.3 million seed round to advance its technology, which uses ...
(RTTNews) - Esperovax, a developer of oral mRNA biologics, and Ginkgo Bioworks (DNA), which is building the leading platform for cell programming and biosecurity, Thursday announced a partnership to ...
On August 16, 2022, Merck (NYSE: MRK) and Orna Therapeutics each announced that they entered into a collaboration agreement relating to the discovery, development and commercialization of therapeutics ...
University of Delaware’s Mona Batish is a molecular biologist. She studies circular RNAs formed as a result of so-called molecular mistakes that occur when a strand of RNA — the ribonucleic acid that ...
“Circular RNA technology is poised to transform vaccine development as well the treatment of cancers, autoimmune and other diseases. Circurna reflects who we are today and the future we are working ...
It’s no secret that we need new ways to treat and detect disease, including cancer. Specifically, we need better biomarkers that can be used for diagnosis and better ways to selectively get medicine ...
This is a preview. Log in through your library . Abstract Circular RNAs (circRNAs) have recently emerged as a novel class of abundant endogenous stable RNAs produced by circularization with regulatory ...
The Mass General Brigham Gene and Cell Therapy Institute (GCTI) today announced it has launched the RNA Therapeutics Core, a first-of-its-kind, state-of-the-art facility and resource to advance the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback